GSTM1 and cancer: Results from our study confirm that DA is more effective than placebo at increasing Hb levels and at reducing the need for RBC or whole blood transfusions in patients with Stage IV cancer and CIA when DA treatment is initiated at baseline Hb ≤10 g/dL.